Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast (Q73931496)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

5

D J Greenblatt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

3

L L von Moltke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

B W Granda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G M Giancarlo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

Biopharmaceutics and Drug Disposition

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

385-388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Leukotriene-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Summary of clinical trials with zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Zafirlukast: The First Leukotreene-Receptor Antagonist Approved for the Treatment of Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

A drug interaction between zafirlukast and theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Alprazolam metabolism in vitro: studies of human, monkey, mouse, and rat liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

In vitro approaches to predicting drug interactions in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-081X%28199911%2920%3A8%3C385%3A%3AAID-BDD203%3E3.0.CO%3B2-7

10.1002/1099-081X(199911)20:8<385::AID-BDD203>3.0.CO;2-7

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870095%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference